Document Detail


Advances in the management of alloimmune thrombocytopenia.
MedLine Citation:
PMID:  17233844     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There have been considerable advances in the clinical and laboratory diagnosis of alloimmune thrombocytopenia (AIT), and its postnatal and antenatal management. The antenatal management of AIT has been particularly problematic, because severe haemorrhage occurs as early as 16 weeks gestation and there is no non-invasive investigation that reliably predicts the severity of AIT in utero. The strategies for antenatal treatment have included the use of serial platelet transfusions that, while effective, are invasive and associated with significant morbidity and mortality. Maternal therapy involving the administration of intravenous immunoglobulin and/or steroids is also effective and associated with fewer risks to the fetus. Significant recent progress has involved refinement of maternal treatment, stratifying it according to the likely severity of AIT based on the history in previous pregnancies. However, the ideal antenatal treatment, which is effective without causing significant side-effects to the mother or fetus, has yet to be determined, and further clinical trials are needed.
Authors:
Michael F Murphy; James B Bussel
Related Documents :
24995104 - A new classification system for pregnancy prognosis of tubal factor infertility.
20071824 - Antenatal diagnosis of large sacro-coccygeal teratoma with foetal cardiomegaly and hydr...
20638314 - Should pmm2-deficiency (cdg ia) be searched in every case of unexplained hydrops fetalis?
24384024 - The impact of gestational thyroid hormone concentrations on adhd symptoms of the child.
17939604 - Discordance of fetal genotype or phenotype in monozygotic twins: a report of 2 cases.
11885234 - Extraction and quantification of heparin in "clinically normal" and inflamed gingiva of...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  British journal of haematology     Volume:  136     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-01-19     Completed Date:  2007-03-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  366-78     Citation Subset:  IM    
Affiliation:
National Blood Service, Department of Haematology, John Radcliffe Hospital, University of Oxford, Oxford, UK. mike.murphy@nbs.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Transfusion, Intrauterine
Cost-Benefit Analysis
Female
Fetal Diseases / diagnosis*,  immunology,  therapy
Glucocorticoids / therapeutic use
Humans
Immunoglobulins, Intravenous
Infant, Newborn
Platelet Transfusion
Pregnancy
Pregnancy Complications, Hematologic / diagnosis*,  immunology,  therapy
Prenatal Diagnosis / methods
Thrombocytopenia / diagnosis*,  immunology,  therapy
Chemical
Reg. No./Substance:
0/Glucocorticoids; 0/Immunoglobulins, Intravenous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The recombinant kringle domain of urokinase plasminogen activator inhibits in vivo malignant glioma ...
Next Document:  Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell li...